Tirzepatide (LY3298176) is a novel dual GIP and GLP-1 receptor agonist developed for the treatment of type 2 diabetes and obesity. This synthetic peptide demonstrates superior glycemic control and weight loss effects compared to single GLP-1 receptor agonists.
Our tirzepatide is supplied as lyophilized powder in pharmaceutical grade purity (99%) with molecular weight 4813. The product undergoes rigorous quality control including HPLC and MS analysis to ensure batch-to-batch consistency.
Key features of our tirzepatide uk price offering include:
- Multiple dosage options from 5mg to 60mg per vial
- Custom formulations available
- Stable lyophilized form for long-term storage
- Strict cold chain transportation
As a research chemical, this product is intended for laboratory use only. Not for human consumption. Researchers should handle with proper protective equipment and storage conditions.